stockrowFocalTherics (FOCL) vs Henry Schein, Inc. (HSIC)
- FocalTherics FOCL 3.79 −10.82%
- Henry Schein, Inc. HSIC 85.45 +0.16%
FocalTherics and Henry Schein, Inc. are both Medical Distribution companies. Henry Schein, Inc. is the larger, with a market value of $9.4B against $159.3M — 59.2× the size. FocalTherics has negative trailing earnings, so its P/E is not meaningful; Henry Schein, Inc. trades at 22.8×. FocalTherics grew revenue faster over the last twelve months: 29.5% against 6.15%. Henry Schein, Inc. has the higher net margin (3.07% vs −50.1%) and the higher return on invested capital (7.20% vs −110.8%). Across the 18 metrics below, Henry Schein, Inc. leads on 11 and FocalTherics on 7.
Valuation
Profitability
| Metric | FOCL | HSIC | Medical Distribution median |
|---|---|---|---|
| Gross margin | 44.53% | 31.59% | 5.74% |
| Operating margin | (34.93%) | 5.16% | 0.00% |
| Net margin | (50.11%) | 3.07% | (11.41%) |
| Free cash flow margin | (24.60%) | 4.07% | (0.36%) |
| Return on equity | (133.48%) | 10.74% | 0.00% |
| Return on assets | (50.28%) | 3.72% | (1.95%) |
| Return on invested capital | (110.75%) | 7.20% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack